OpenAlex
PricingAboutJobs
Log inGet started
Work

Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy

HTML

Year: 2008
Type: article
Study design: Clinical Trial
Source: Gastroenterology
DOI: 10.1053/j.gastro.2008.07.072
Authors: Peter Ferenci, Thomas–Matthias Scherzer, Heidrun Kerschner, Karoline Rutter, Sandra Beinhardt, Harald Hofer, Maximilian Schöniger–Hekele, Heidemarie Holzmann, Petra Steindl–Munda
Institution: Medical University of Vienna
Language: English

Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: silibinin, chronic hepatitis C, antiviral therapy, pegylated interferon, ribavirin, treatment non-responders, HCV RNA viral load, combination therapy, dose-dependent effects, drug tolerability, silymarin, interferon resistance, HCV genotype 1b, HCV genotype 3a, HCV genotype 2
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2083100985
FWCI: 14.55
Cites: 28
Cited by: 269
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms